Cargando…

Everolimus and Malignancy after Solid Organ Transplantation: A Clinical Update

Malignancy after solid organ transplantation remains a major cause of posttransplant mortality. The mammalian target of rapamycin (mTOR) inhibitor class of immunosuppressants exerts various antioncogenic effects, and the mTOR inhibitor everolimus is licensed for the treatment of several solid cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holdaas, Hallvard, De Simone, Paolo, Zuckermann, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078653/ https://www.ncbi.nlm.nih.gov/pubmed/27807479 http://dx.doi.org/10.1155/2016/4369574

Ejemplares similares

Everolimus in Heart Transplantation: An Update
por: Hirt, Stephan W., et al.
Publicado: (2013)

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

1383. Everolimus is Associated with an Increased Risk of Tuberculosis in Solid-Organ Transplant Recipients
por: Sun, Hsin-Yun, et al.
Publicado: (2019)

Everolimus-eluting stents: update on current clinical studies
por: Allocco, Dominic J, et al.
Publicado: (2011)

Immune checkpoint inhibitors for solid organ transplant recipients: clinical updates
por: Kawashima, Shun, et al.
Publicado: (2022)

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group
por: De Simone, Paolo, et al.
Publicado: (2017)

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
por: Ussif, Amin, et al.
Publicado: (2018)

Updates on Histoplasmosis in Solid Organ Transplantation
por: Saullo, Jennifer L., et al.
Publicado: (2022)

The role of everolimus in liver transplantation
por: Ganschow, Rainer, et al.
Publicado: (2014)

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study
por: Abedini, Sadollah, et al.
Publicado: (2018)

The use of everolimus in renal-transplant patients
por: Pascual, Julio
Publicado: (2009)

COVID-19 in Solid Organ Transplantation: Disease Severity and Clinical Update
por: Arya, Akanksha, et al.
Publicado: (2021)

Bacteremia During the First Year After Solid Organ Transplantation: An Epidemiological Update
por: Neofytos, Dionysios, et al.
Publicado: (2023)

Utility of CMV-Specific Immune Monitoring for the Management of CMV in Solid Organ Transplant Recipients: A Clinical Update
por: Prakash, Katya, et al.
Publicado: (2021)

Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge
por: Avery, Robin Kimiko
Publicado: (2022)

Use of everolimus in liver transplantation
por: Yee, Mei-Ling, et al.
Publicado: (2017)

Interstitial Lung Disease Associated with mTOR Inhibitors in Solid Organ Transplant Recipients: Results from a Large Phase III Clinical Trial Program of Everolimus and Review of the Literature
por: Lopez, Patricia, et al.
Publicado: (2014)

Macrophages in solid organ transplantation
por: Jiang, Xinguo, et al.
Publicado: (2014)

Intermittent everolimus administration for malignant insulinoma
por: Baratelli, Chiara, et al.
Publicado: (2014)

Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial
por: Zuckermann, Andreas, et al.
Publicado: (2011)

Combination of Everolimus with Sorafenib for Solid Renal Tumors in Tsc2(+/−) Mice Is Superior to Everolimus Alone()
por: Yang, Jian, et al.
Publicado: (2017)

Long-term outcomes of children after solid organ transplantation
por: Kim, Jon Jin, et al.
Publicado: (2014)

Update on the everolimus-eluting coronary stent system: results and implications from the SPIRIT clinical trial program
por: Kirchner, R Michael, et al.
Publicado: (2009)

Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
por: Kang, Incheon, et al.
Publicado: (2021)

Tuberculosis in Solid Organ Transplantation
por: Alizadeh, Afshin Mohammad, et al.
Publicado: (2016)

Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update
por: Abad, Cybele L., et al.
Publicado: (2016)

Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
por: Martel, Arnaud, et al.
Publicado: (2020)

Cryptosporidium infection in solid organ transplantation
por: Florescu, Diana F, et al.
Publicado: (2016)

Regulatory T cells in solid organ transplantation
por: Atif, Muhammad, et al.
Publicado: (2020)

Viral Enteritis in Solid-Organ Transplantation
por: Abbas, Anum, et al.
Publicado: (2021)

Immune Checkpoints in Solid Organ Transplantation
por: Del Bello, Arnaud, et al.
Publicado: (2023)

Posttransplant Lymphoproliferative Disease after Pediatric Solid Organ Transplantation
por: Mynarek, Martin, et al.
Publicado: (2013)

Use of Statins in Kidney Transplant Recipients in Norway
por: Rønning, Marit, et al.
Publicado: (2022)

Current Status of Malignant Tumors after Organ Transplantation
por: Shen, Bairu, et al.
Publicado: (2022)

Emergency abdominal surgery after solid organ transplantation: a systematic review
por: de’Angelis, Nicola, et al.
Publicado: (2016)

Vaccination Recommendations in Solid Organ Transplant Adult Candidates and Recipients
por: Viganò, Mauro, et al.
Publicado: (2023)

Everolimus in Invasive Malignant Renal Epithelioid Angiomyolipoma
por: Guo, Gang, et al.
Publicado: (2021)

Clinical remission of an inoperable malignant insulinoma by the combination treatment with octreotide and everolimus
por: Akahori, Hiroshi
Publicado: (2019)

SARS-CoV-2 Vaccination in Solid-Organ Transplant Recipients
por: Peghin, Maddalena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o7102fmc1k1qilhu4cj60vaa9a